Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Research and Innovation Action · Running

IMPACT-MED Improving patients' outcomes & fragmented specialized care through a connected & advanced Multidisciplinary-Cardio-Metabolic-Clinic

Coordinator
Universita Campus Bio Medico Di Roma, Italy
Runs
1 April 2026 to 31 March 2031
Status
Running
EU funding
€14.2m
Total cost
€22.9m
Partners
26 organisations in 13 countries
Type
Research and Innovation Action
Grant agreement
101253530

What the project is doing

In the project's own words, from its summary on CORDIS.

Cardiometabolic diseases—hypertension (HTN), obesity, type 1 and 2 diabetes (T1DM, T2DM), coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and heart valve disease (HVD)—often coexist, are diagnosed late, and are among the leading causes of death and disability in Europe, accounting for over 4 million deaths annually and creating major clinical and economic burdens. Multimorbid patients face fragmented care due to disconnected pathways, unequal access, and lack of integration, personalization, proactivity, and digital support.

IMPACT-MED addresses these gaps by designing, developing, and deploying an innovative, scalable, and people-centred Multidisciplinary Cardio-Metabolic Care (MCMC) framework, supported by a clinically enriched digital ecosystem combining mature (TRL>8) and innovative (TRL>5) technologies and services. It aims to build productive public-private collaboration, overcoming fragmented and siloed solutions, and preventing institution- or industry-driven models, ultimately enabling a people-centred continuum of care tailored to patients’ capacity (low, moderate, high) in suffering, coping, and managing cardiometabolic conditions.

This transformative model supports proactive, continuous care through integrated health solutions such as AI-based risk stratification, predictive algorithms, remote monitoring, advanced imaging, and patient-centred data collection tools. Four use cases (UC1: AI-based BP management; UC2: remote monitoring post-MI; UC3: T1DM self-management; UC4: T2DM phenotyping and care) will operationalize and validate the MCMC models.

The framework will empower patients, guide clinicians, optimize pathways, and support continuous disease management. IMPACT-MED will deliver a robust MCMC framework and share with the MCMC community an observatory dashboard with validated expansion and sustainability guidelines and a regulatory strategy to ensure long-term success and global scalability.

Topics

Who is involved

OrganisationCityCountryRole
Universita Campus Bio Medico Di RomaRomaItalyCoordinator
HictGentBelgiumParticipant
Medtronic International Trading SARLTolochenazSwitzerlandParticipant
Siemens Healthineers AGForchheimGermanyParticipant
Aalborg UniversitetAalborgDenmarkParticipant
Region Nordjylland (north Denmark Region)AalborgDenmarkParticipant
Bridg OuTallinEstoniaParticipant
Ethniko Kentro Erevnas Kai Technologikis AnaptyxisThermi ThessalonikiGreeceParticipant
CardioalianzaMadridSpainParticipant
Fundacion Para La Investigacion Biomedica Del Hospital Universitario Clinico San CarlosMadridSpainThird party
Happy Mondays Communication SLMadridSpainParticipant
Medtronic Iberica SAMadridSpainParticipant
Predictby Research and Consulting S.l.BarcelonaSpainParticipant
Servicio Madrileno De SaludMadridSpainParticipant
A.c.t.i.o.n Allies in Cardiovascular Trials Initiatives and Organized Networks Association-CoeurParisFranceParticipant
Assistance Publique Hopitaux De ParisParisFranceParticipant
Medtronic FranceBoulogneFranceParticipant
The European Association for the Study of Obesity - Ireland Company Limited by GuaranteeDublinIrelandParticipant
The European Coalition for People Living with Obesity Company Limited by GuaranteeDublinIrelandParticipant
Siemens Healthcare Private LimitedVikhroli EastIndiaAssociatedpartner
Fwdfaster Ai Research BVUtrechtNetherlandsParticipant
Samenwerkende Topklinische OpleidingsziekenhuizenUtrechtNetherlandsParticipant
Digibete C.i.c.Leeds, YorkshireUnited KingdomParticipant
Perspectum LtdOxfordUnited KingdomParticipant
Samsung Electronics (UK) LimitedChertsey - SurreyUnited KingdomParticipant
The Leeds Teaching Hospitals National Health Service TrustLeedsUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI